David A. Siegel Sensus Healthcare, Inc. Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Sensus Healthcare, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 80,700 shares of SRTS stock, worth $430,131. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80,700
Previous 88,500
8.81%
Holding current value
$430,131
Previous $208,000
47.12%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding SRTS
# of Institutions
48Shares Held
2.47MCall Options Held
2.2KPut Options Held
3K-
Vanguard Group Inc Valley Forge, PA779KShares$4.15 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny291KShares$1.55 Million0.0% of portfolio
-
Perritt Capital Management Inc Chicago, IL131KShares$696,0230.28% of portfolio
-
Geode Capital Management, LLC Boston, MA128KShares$680,1980.0% of portfolio
-
Invenire Partners, LP Ridgefield, CT119KShares$633,561100.0% of portfolio
About Sensus Healthcare, Inc.
- Ticker SRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 16,556,000
- Market Cap $88.2M
- Description
- Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...